The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells
2010 · BMC Cancer · 49 citations
https://doi.org/10.1186/1471-2407-10-560
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
784
Citations
9
h-index
9
i10-index
Meike Dahlhaus is an academic researcher from University Hospital Ulm. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism & Chronic Lymphocytic Leukemia Research. The author has an h-index of 9, co-authored 17 publications.
https://doi.org/10.1186/1471-2407-10-560
https://doi.org/10.1007/s00018-020-03699-1
https://doi.org/10.1038/s41598-017-05932-7
https://doi.org/10.1210/me.2009-0220
Click to start Chat